Dopamine Hcl Fresenius 200 Mg/5 Ml 200 mg/5 ml Solution for infusion.
PDF Leaflet Revision Date: 18 May 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Used in shock, myocardial infarction, trauma, septic shock, and chronic refractory heart failure.
Dosage (summary)
Initial rate: 2-5 u03bcg/kg/min, increase as needed up to 20-50 u03bcg/kg/min.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- MAO inhibitors
- Tricyclic antidepressants
- Beta blockers
- Ergotamine
Contraindications
- Hypersensitivity to dopamine
- Phaeochromocytoma
- Uncorrected tachydysrhythmias
- Pregnancy
- Lactation
Common side effects
- Headache
- Tachycardia
- Nausea
- Hypotension
Counselling Points
- Infuse into a large vein
- Monitor infusion site
- Avoid abrupt discontinuation
Serious warnings
- Monitor blood pressure and renal function
- Risk of tissue necrosis
- Caution with anaesthetics
Important Disclaimer
The Dopamine Hcl Fresenius 200 Mg/5 Ml 200 mg/5 ml Solution for infusion. professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
